Sun Pharma Sued Over Patent on Sedative for Intubated Patients

Sun Pharmaceutical was accused in a lawsuit by WG Critical Care and ACS Dobfar’s InfoRLife of infringing a patent by proposing a generic version of an intravenous, continuously infused sedative used during treatment in a critical care setting.

• InfoRLife and WG Critical Care are seeking court order blocking copies while case proceeds and until patent has expired, according to complaint filed Friday in federal court in Wilmington, Delaware
• Sun’s proposed copycat is of the 100-milligrams-per-100-milliliters dose of midazolam in 0.9% sodium chloride solution, a continuous intravenous infusion for the sedation of intubated and mechanically ventilated patients: complaint
• Patent expires ...